Support Arthritis Research at the National Institutes of Health
Arthritis Has a Devastating Effect on Our Nation
Research holds the key to preventing, controlling, and curing arthritis, the nation’s leading cause of disability. The prevalence, impact and disabling pain continues to increase. More than 50 million Americans — one in five adults — have arthritis now. Within 20 years, the Centers for Disease Control and Prevention estimate 67 million adults or 25% of the population will have arthritis. Arthritis limits the daily activities of 21 million Americans and accounts for $156 billion annually in economic costs.
Support Research at NIAMS to Improve Lives
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases. The critical research done at NIAMS improves the quality of life for people with arthritis and decreases the overall burden of the disease. The research conducted at NIAMS includes:
- Cartilage regeneration studies for patients with osteoarthritis (OA), which afflicts 27 million Americans. This innovation could lead to the first disease-reversing drug to be available for patients with OA.
- A randomized, controlled trial on the effectiveness of daily calcium supplementation for increasing bone mineral density in children with juvenile arthritis (JA). The trial found that supplementation resulted in a statically significant increase in total body mineral density compared with a placebo in children with JA.
- The NIAMS Community Health Center study on health disparities in rheumatic diseases. To date, over 200 people have participated in the Natural History of Rheumatic Disease in Minority Communities Study, which provides greater insights rheumatoid arthritis (RA), and other forms of arthritis, in minority populations.
- Genome-wide association studies and in-depth follow-up analysis in rheumatic diseases. The study will provide insights into genetic risk for these conditions and identify potential therapeutic targets.